|

CG-0255 Besylate for Injection Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Shanghai CureGene Pharmaceutical Co., Ltd.1

Indications

  • Recent Stroke1
  • Recent Myocardial Infarction1
  • Acute Coronary Syndromes (ACS)1
  • Heart Disease1
  • Peripheral Arterial Disease1

Miami, Florida1 trial

The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate）and Plavix® in Healthy Participants

Syneos Health

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.